Jack W. Callicutt

CIK: 0001266773

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)22 (46.8%)

Position reduction

Option Exercises (M)21 (44.7%)

Derivative conversions

Awards (A)4 (8.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALT

GALECTIN THERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (47 total)

GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Restricted Stock Unit
Direct
100K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
65K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 6, 2026
Sale(S)
Direct
20.4K shares at avg. $3.67$75K
GALT
GALECTIN THERAPEUTICS INC
Jan 5, 2026
Sale(S)
Direct
25.7K shares at avg. $3.90$100K
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Sale(S)
Direct
13.9K shares at avg. $4.20$58K
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Exercise(M)
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 1, 2026
Exercise(M)
Restricted Stock Unit
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Sale(S)
Direct
18.2K shares at avg. $6.22$113K
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Exercise(M)
Direct
28.1K shares at avg. $1.98$56K
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Sale(S)
Direct
28.1K shares at avg. $6.22$175K
GALT
GALECTIN THERAPEUTICS INC
Nov 18, 2025
Exercise(M)
Direct
18.2K shares at avg. $1.11$20K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Sale(S)
Direct
9.6K shares at avg. $6.03$58K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Sale(S)
Direct
19.7K shares at avg. $6.03$119K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Exercise(M)
Direct
9.6K shares at avg. $1.98$19K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Exercise(M)
Direct
2.3K shares at avg. $1.23$3K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Sale(S)
Direct
2.3K shares at avg. $6.03$14K
GALT
GALECTIN THERAPEUTICS INC
Nov 17, 2025
Exercise(M)
Direct
19.7K shares at avg. $1.11$22K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Exercise(M)
Direct
1.7K shares at avg. $1.11$2K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Exercise(M)
Direct
1.9K shares at avg. $1.98$4K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Sale(S)
Direct
1.9K shares at avg. $6.02$11K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Sale(S)
Direct
1.7K shares at avg. $6.03$10K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Exercise(M)
Direct
1.7K shares at avg. $1.23$2K
GALT
GALECTIN THERAPEUTICS INC
Nov 10, 2025
Sale(S)
Direct
1.7K shares at avg. $6.03$10K
GALT
GALECTIN THERAPEUTICS INC
Nov 5, 2025
Exercise(M)
Direct
200 shares at avg. $1.98$396
GALT
GALECTIN THERAPEUTICS INC
Nov 5, 2025
Sale(S)
Direct
200 shares at avg. $6.00$1K

		Type	Shares	Price		Ownership
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Restricted Stock Unit	100,000	-	-	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	65,000	-	-	Direct
Jan 6, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	20,354	$3.67	$74,695	Direct
Jan 5, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	25,732	$3.90	$100,298	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	13,914	$4.20	$58,394	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	60,000	-	$0	Direct
Jan 1, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M) Restricted Stock Unit	60,000	-	-	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	18,210	$6.22	$113,321	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	28,100	$1.98	$55,638	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	28,100	$6.22	$174,866	Direct
Nov 18, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	18,210	$1.11	$20,213	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	9,586	$6.03	$57,820	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	19,701	$6.03	$118,831	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	9,586	$1.98	$18,980	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	2,323	$1.23	$2,857	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	2,323	$6.03	$14,012	Direct
Nov 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	19,701	$1.11	$21,868	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	1,675	$1.11	$1,859	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	1,880	$1.98	$3,722	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	1,880	$6.02	$11,321	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	1,675	$6.03	$10,095	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	1,736	$1.23	$2,135	Direct
Nov 10, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	1,736	$6.03	$10,468	Direct
Nov 5, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	200	$1.98	$396	Direct
Nov 5, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	200	$6.00	$1,200	Direct

1-25 of 47 transactions

About CALLICUTT JACK W

CALLICUTT JACK W (SEC CIK 0001266773) files insider reports with the SEC as Chief Financial Officer of GALECTIN THERAPEUTICS INC (GALT).

Signal8 holds 9 ownership filings by CALLICUTT JACK W, all Form 4s, filed between Dec 26, 2024 and Jan 21, 2026. Those filings report 47 transactions, from Dec 23, 2024 to Jan 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CALLICUTT JACK W's filings is in NORCROSS, GA.

Recent filings by CALLICUTT JACK W

Jan 16, 2026: Grants or awards of GALT derivative securities (2 lines, Form 4, code A).
Jan 6, 2026: Open-market sale of GALT shares (Form 4, code S).
Jan 5, 2026: Open-market sale of GALT shares (Form 4, code S).
Jan 2, 2026: Open-market sale of GALT shares (Form 4, code S).
Jan 2, 2026: Option exercise of GALT shares (Form 4, code M).

Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)

Uihlein Richard E, Director
Jamil Khurram, Chief Medical Officer
Shlevin Harold H., Director
Brem Henry, Director
ELDRED KARY, Director
LEWIS JOEL, President and CEO

How to read Form 4 transaction codes